Drug Interaction Study Of Filibuvir With Methadone Among Subjects On Chronic Methadone Maintenance
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
Filibuvir, a CYP3A4 inhibitor is being developed for the treatment of chronic Hepatitis C
infection. Given the likelihood of co administration of filibuvir and methadone, this study
will evaluate the effect of filibuvir on the pharmacokinetics of R/S Methadone.